News
FDA Ponders Vaccines From Human Tumor Cell Lines
- Author:
- Cathy Dombrowski
Publish date: August 2, 2012
News
Obesity Drugs' CV Risk Assessment Needs Hard End Points
- Author:
- Cathy Dombrowski
Publish date: April 5, 2012
News
FDA Says Weight Loss Drug Needs CV Outcome Trial
- Author:
- Cathy Dombrowski
Publish date: February 21, 2012
News
FDA Questions Earlier Denosumab Use in Prostate Cancer
- Author:
- Cathy Dombrowski
Publish date: February 7, 2012
News
FDA Panel to Assess Azilect Trial Design
- Author:
- Cathy Dombrowski
Publish date: October 14, 2011
News
FDA Considers Infliximab for Pediatric Ulcerative Colitis Maintenance
- Author:
- Cathy Dombrowski
Publish date: July 20, 2011
News
FDA Panel to Review Adcetris for Lymphoma Indications
- Author:
- Cathy Dombrowski
Publish date: July 13, 2011
News
FDA Advisory Panel Supports Hereditary Angioedema Drug
- Author:
- Cathy Dombrowski
Publish date: June 24, 2011
News
FDA Wants Advice on Infection Recurrence with Fidaxomicin
- Author:
- Cathy Dombrowski
Publish date: April 4, 2011
News
FDA Wants Advice on Infection Recurrence with Fidaxomicin
- Author:
- Cathy Dombrowski
Publish date: April 4, 2011
News
FDA Wants Advice on Infection Recurrence with Fidaxomicin
- Author:
- Cathy Dombrowski
Publish date: April 4, 2011
News
FDA: Oncology Drug Makers Should Resist Single-Arm Trials
- Author:
- Cathy Dombrowski
Publish date: February 9, 2011
News
FDA: Oncology Drug Makers Should Resist Single-Arm Trials
- Author:
- Cathy Dombrowski
Publish date: February 9, 2011
News
FDA, Orexigen Discussing CV Risk Study for Weight-Loss Drug Contrave
- Author:
- Cathy Dombrowski
Publish date: December 6, 2010
News
FDA, Orexigen Discussing CV Risk Study for Weight-Loss Drug Contrave
- Author:
- Cathy Dombrowski
Publish date: December 6, 2010